{"component": "clause", "props": {"groups": [{"samples": [{"hash": "k6RYECjgo2C", "uri": "/contracts/k6RYECjgo2C#research-program-term", "label": "Preliminary Research, Development and Marketing Agreement (Tularik Inc)", "score": 18.0, "published": true}, {"hash": "edcoroFZCoz", "uri": "/contracts/edcoroFZCoz#research-program-term", "label": "Preliminary Research, Development and Marketing Agreement (Tularik Inc)", "score": 18.0, "published": true}, {"hash": "dzmateT4xcM", "uri": "/contracts/dzmateT4xcM#research-program-term", "label": "Preliminary Research, Development and Marketing Agreement (Tularik Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "period-of-five-years", "type": "definition", "offset": [51, 71]}, {"key": "agreement-date", "type": "definition", "offset": [93, 107]}, {"key": "prior-written-notice", "type": "definition", "offset": [179, 199]}, {"key": "at-the-end-of-the", "type": "clause", "offset": [261, 278]}, {"key": "any-time", "type": "definition", "offset": [390, 398]}, {"key": "during-the-research-program-term", "type": "clause", "offset": [399, 431]}, {"key": "potential-products", "type": "definition", "offset": [529, 547]}, {"key": "commercially-viable", "type": "definition", "offset": [561, 580]}, {"key": "in-case-of", "type": "clause", "offset": [582, 592]}, {"key": "by-jt", "type": "clause", "offset": [619, 624]}, {"key": "due-and-payable", "type": "clause", "offset": [719, 734]}, {"key": "date-of", "type": "clause", "offset": [755, 762]}, {"key": "termination-of-the-research-program", "type": "clause", "offset": [801, 836]}, {"key": "in-accordance-with", "type": "definition", "offset": [907, 925]}, {"key": "section-13", "type": "definition", "offset": [926, 936]}, {"key": "collaboration-lead-compound", "type": "definition", "offset": [1006, 1033]}, {"key": "future-date", "type": "definition", "offset": [1184, 1195]}, {"key": "pursuant-to-sections", "type": "clause", "offset": [1302, 1322]}, {"key": "development-of", "type": "clause", "offset": [1354, 1368]}, {"key": "an-independent", "type": "clause", "offset": [1369, 1383]}, {"key": "granted-by", "type": "definition", "offset": [1447, 1457]}, {"key": "worldwide-license", "type": "clause", "offset": [1546, 1563]}, {"key": "lead-compounds", "type": "definition", "offset": [1612, 1626]}, {"key": "program-patents", "type": "definition", "offset": [1662, 1677]}, {"key": "conditions-to", "type": "clause", "offset": [1727, 1740]}, {"key": "patent-rights", "type": "definition", "offset": [1855, 1868]}, {"key": "to-the-extent", "type": "clause", "offset": [1882, 1895]}, {"key": "to-practice", "type": "clause", "offset": [1906, 1917]}, {"key": "license-granted", "type": "clause", "offset": [1922, 1937]}, {"key": "the-program", "type": "clause", "offset": [1944, 1955]}, {"key": "with-respect-to", "type": "clause", "offset": [2004, 2019]}, {"key": "a-limited", "type": "clause", "offset": [2031, 2040]}, {"key": "number-of", "type": "clause", "offset": [2041, 2050]}, {"key": "library-compounds", "type": "definition", "offset": [2056, 2073]}, {"key": "approved-by", "type": "definition", "offset": [2074, 2085]}, {"key": "in-the-event-the", "type": "clause", "offset": [2115, 2131]}, {"key": "discontinued-compound", "type": "definition", "offset": [2806, 2827]}, {"key": "a-non", "type": "clause", "offset": [2831, 2836]}, {"key": "first-anniversary", "type": "definition", "offset": [2872, 2889]}, {"key": "expiration-or-termination", "type": "clause", "offset": [2897, 2922]}, {"key": "the-development", "type": "clause", "offset": [3154, 3169]}, {"key": "clinical-development-and-registration", "type": "clause", "offset": [3279, 3316]}, {"key": "obligation-to", "type": "clause", "offset": [3375, 3388]}], "size": 7, "snippet": "The Research Program shall be conducted during the period of five years commencing as of the Agreement Date (\"Research Program Term\"). Upon not later than seventy-five (75) days' prior written notice JT may, in its sole judgment, terminate the Research Program at the end of the third (3/rd/) year and fourth (4/th/) year of the Research Program. The RMC may terminate the Research Program any time during the Research Program Term if it unanimously determines the Research Program is no longer scientifically useful or that all potential Products would not be commercially viable. In case of such an early termination by JT or the RMC, JT shall be exempt from any payment(s) under Section 10(a) that would have become due and payable after the effective date of such early termination. Following any termination of the Research Program (i) that occurs simultaneously with the termination of this Agreement in accordance with Section 13 (i.e., no compound or Lead Compound has been designated previously a Collaboration Lead Compound in accordance with Section 3(b) and no Independent Lead Compound is being developed in accordance with Section 3(m)) or (ii) that is followed at some future date by the termination by JT of Development or co-promotion of any Collaboration Lead Compound and/or Product pursuant to Sections 3(l) or 5(c), respectively, or development of an Independent Lead Compound in accordance with Section 3(m) (A) any licenses granted by Tularik to JT will terminate, (B) JT will grant to Tularik an exclusive, sublicensable, worldwide license, to make, use and sell compounds, Collaboration Lead Compounds or Products under JT's interest in Program Patents and Program Know-How and (C) under the terms and conditions to be separately agreed, JT will also grant to Tularik a nonexclusive, sublicensable, worldwide license under any JT Patent Rights and Know-How to the extent necessary to practice the license granted under the Program Patents and Program Know-How in (B) (including, with respect to compounds, a limited number of JT's library compounds approved by JT); provided, however, that in the event the Research Program terminates but the Agreement has not terminated with respect to designated Collaboration Lead Compounds, Independent Lead Compounds and/or Products as provided in Section 2(g)(ii), Sections 2(g)(A), (B) and (C) shall apply only to those compounds, Collaboration Lead Compounds, Independent Lead Compounds and Products for which Development or co-promotion shall have been terminated and/or to those compounds or Lead Compounds that have not been designated previously a Collaboration Lead Compound in accordance with Section 3(b) or an Independent Lead Compound in accordance with Section 3(m); provided further that in the event that JT elects to pursue a Discontinued Compound or a Non-Proposed Compound on or before the first anniversary of the expiration or termination of the Research Program Term pursuant to Section 3(b)(iii) or 3(b)(iv), respectively, Sections 2(g)(A), (B) and (C) shall not apply to such Discontinued Compound or Non-Proposed Compound until such time as JT shall have terminated the Development or co-promotion of such Discontinued Compound or Non- Proposed Compound. Tularik will then be free to pursue clinical development and registration of such compounds, Lead Compounds and/or Products without obligation to JT except as provided in Section 4(f) or Section 5(c), as appropriate.", "hash": "ac572686368718d9308f7b2ea43802fc", "id": 1}, {"samples": [{"hash": "fjGaunlPWZL", "uri": "/contracts/fjGaunlPWZL#research-program-term", "label": "Collaboration Agreement (Genvec Inc)", "score": 18.0, "published": true}, {"hash": "bn88r2Ivt7E", "uri": "/contracts/bn88r2Ivt7E#research-program-term", "label": "Collaboration Agreement (Genvec Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "term-of-the-research-program", "type": "clause", "offset": [4, 32]}, {"key": "on-the-effective-date", "type": "clause", "offset": [70, 91]}, {"key": "pursuant-to-section", "type": "definition", "offset": [123, 142]}, {"key": "article-11", "type": "definition", "offset": [152, 162]}, {"key": "fifth-anniversary", "type": "definition", "offset": [189, 206]}], "size": 6, "snippet": "The term of the Research Program shall --------------------- commence on the Effective Date and, unless terminated earlier pursuant to Section 2.6.2 or Article 11, shall continue until the fifth anniversary of the Effective Date (the \"Research Program Term\").", "hash": "bf81ffb2ed168b40312c8ca2b1020272", "id": 2}, {"samples": [{"hash": "ckseCjAqSjZ", "uri": "/contracts/ckseCjAqSjZ#research-program-term", "label": "Exclusive Patent License and Research Collaboration Agreement", "score": 31.340862423, "published": true}, {"hash": "4FfVKKNQx56", "uri": "/contracts/4FfVKKNQx56#research-program-term", "label": "Exclusive Patent License and Research Collaboration Agreement", "score": 31.340862423, "published": true}, {"hash": "jShGsdrqdBJ", "uri": "/contracts/jShGsdrqdBJ#research-program-term", "label": "Exclusive Patent License and Research Collaboration Agreement (Cue Biopharma, Inc.)", "score": 28.947980835, "published": true}], "snippet_links": [{"key": "term-of-the-research-program", "type": "clause", "offset": [4, 32]}, {"key": "on-the-effective-date", "type": "clause", "offset": [48, 69]}, {"key": "election-of", "type": "clause", "offset": [107, 118]}, {"key": "product-candidates", "type": "clause", "offset": [126, 144]}, {"key": "from-the-effective-date", "type": "clause", "offset": [161, 184]}], "size": 5, "snippet": "The term of the Research Program shall commence on the Effective Date and continue until the later of: (i) election of [****] Product Candidates; or (ii) [****] from the Effective Date, except as provided below in Section 2.10.1 or as otherwise stated herein.", "hash": "54ce9752d83ef761d6782b01a32ed31a", "id": 3}, {"samples": [{"hash": "iMi8lfNULNA", "uri": "/contracts/iMi8lfNULNA#research-program-term", "label": "Research Collaboration and License Agreement", "score": 31.340862423, "published": true}, {"hash": "2uEVDoPG5aV", "uri": "/contracts/2uEVDoPG5aV#research-program-term", "label": "Research Collaboration and License Agreement", "score": 31.340862423, "published": true}, {"hash": "chpinkxbv8v", "uri": "/contracts/chpinkxbv8v#research-program-term", "label": "Research Collaboration and License Agreement (Arvinas Holding Company, LLC)", "score": 29.7008898015, "published": true}], "snippet_links": [{"key": "except-as-otherwise-provided", "type": "clause", "offset": [0, 28]}, {"key": "term-of-the-research-program", "type": "clause", "offset": [41, 69]}, {"key": "on-the-effective-date", "type": "clause", "offset": [111, 132]}, {"key": "in-accordance-with", "type": "definition", "offset": [166, 184]}, {"key": "terms-of-this-agreement", "type": "clause", "offset": [189, 212]}, {"key": "completion-of-the", "type": "clause", "offset": [235, 252]}, {"key": "to-be-completed", "type": "clause", "offset": [258, 273]}, {"key": "research-plan", "type": "definition", "offset": [288, 301]}, {"key": "provided-that", "type": "clause", "offset": [303, 316]}, {"key": "first-stage", "type": "definition", "offset": [358, 369]}, {"key": "initial-targets", "type": "clause", "offset": [400, 415]}, {"key": "substitute-target", "type": "definition", "offset": [620, 637]}, {"key": "the-relevant", "type": "clause", "offset": [697, 709]}, {"key": "target-substitution-notice", "type": "definition", "offset": [710, 736]}, {"key": "section-35", "type": "clause", "offset": [756, 767]}, {"key": "relevant-time-period", "type": "definition", "offset": [818, 838]}, {"key": "no-fault", "type": "clause", "offset": [847, 855]}, {"key": "no-obligation-to", "type": "clause", "offset": [887, 903]}, {"key": "relevant-portion", "type": "definition", "offset": [916, 932]}], "size": 5, "snippet": "Except as otherwise provided herein, the term of the Research Program (\u201cResearch Program Term\u201d) shall commence on the Effective Date and, unless otherwise terminated in accordance with the terms of this Agreement, shall continue until completion of the last to be completed or terminated Research Plan; provided that Pfizer agrees that it shall Initiate the first Stage of the Research Plan for [**] Initial Targets within [**] of the Effective Date and for each additional Initial Target that remains a Target hereunder within [**] of the Effective Date, and shall Initiate the first Stage of the Research Plan for any Substitute Target that becomes and remains a Target hereunder within [**] of the relevant Target Substitution Notice issued pursuant to Section 3.5. If any Research Plan is not Initiated within the relevant time period through no fault of Arvinas, Arvinas shall have no obligation to conduct the relevant portion of the Research Program.", "hash": "a69cb069751d651ce955d3ca28c7dd37", "id": 4}, {"samples": [{"hash": "4kdmCgnEV4b", "uri": "/contracts/4kdmCgnEV4b#research-program-term", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 32.0965092402, "published": true}, {"hash": "23GorjdgR8Q", "uri": "/contracts/23GorjdgR8Q#research-program-term", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 27.1054072553, "published": true}, {"hash": "8YlVMCcMFQr", "uri": "/contracts/8YlVMCcMFQr#research-program-term", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 24.0965092402, "published": true}], "snippet_links": [{"key": "section-1121", "type": "clause", "offset": [11, 25]}, {"key": "period-of", "type": "definition", "offset": [86, 95]}, {"key": "prior-written-notice", "type": "definition", "offset": [162, 182]}, {"key": "periods-of", "type": "clause", "offset": [221, 231]}, {"key": "by-either-party", "type": "clause", "offset": [261, 276]}, {"key": "notice-to-the", "type": "clause", "offset": [331, 344]}, {"key": "other-party", "type": "definition", "offset": [345, 356]}, {"key": "the-parties", "type": "definition", "offset": [369, 380]}, {"key": "mutual-agreement", "type": "definition", "offset": [390, 406]}, {"key": "terms-and-conditions-applicable-to", "type": "clause", "offset": [421, 455]}, {"key": "in-the-event", "type": "clause", "offset": [476, 488]}, {"key": "prior-to-the", "type": "clause", "offset": [518, 530]}, {"key": "termination-of-the-research-program", "type": "clause", "offset": [587, 622]}, {"key": "termination-of-this-agreement", "type": "clause", "offset": [658, 687]}], "size": 5, "snippet": "Subject to Section 11.2.1, the Research Program may be extended (a) for an additional period of one (1) year by \u2587\u2587\u2587\u2587\u2587\u2587 by providing not less than six (6) months\u2019 prior written notice to Enanta and (b) for one (1) or more periods of one (1) year each thereafter by either Party providing not less than six (6) months\u2019 prior written notice to the other Party, subject to the Parties reaching mutual agreement on all of the terms and conditions applicable to any such extension. In the event this Agreement is terminated prior to the end of the Research Program Term, the effective date of termination of the Research Program Term shall be the same date as the termination of this Agreement.", "hash": "6d3712203ffe10b89ceab25bf0de80b5", "id": 5}, {"samples": [{"hash": "5PZYoNse4vh", "uri": "/contracts/5PZYoNse4vh#research-program-term", "label": "Collaboration and Cross License Agreement (Zymeworks Inc.)", "score": 28.2525667351, "published": true}, {"hash": "eKByFnZbzVs", "uri": "/contracts/eKByFnZbzVs#research-program-term", "label": "Collaboration and Cross License Agreement (Zymeworks Inc.)", "score": 26.2142368241, "published": true}], "snippet_links": [{"key": "the-research-program", "type": "clause", "offset": [0, 20]}, {"key": "on-the-effective-date", "type": "clause", "offset": [36, 57]}, {"key": "agreement-of-the-parties", "type": "clause", "offset": [209, 233]}], "size": 5, "snippet": "The Research Program shall commence on the Effective Date and shall conclude [\u2026***\u2026] months thereafter (such period, the \u201cResearch Program Term\u201d). The Research Program Term may be extended upon mutual written agreement of the Parties.", "hash": "276a8b39375a37f64d0e64085c33cace", "id": 6}, {"samples": [{"hash": "lV5k2MHNIGn", "uri": "/contracts/lV5k2MHNIGn#research-program-term", "label": "Collaborative Research and License Agreement (Nitromed Inc)", "score": 21.0, "published": true}, {"hash": "i6GIOhJ5Y6r", "uri": "/contracts/i6GIOhJ5Y6r#research-program-term", "label": "Collaborative Research and License Agreement (Nitromed Inc)", "score": 21.0, "published": true}, {"hash": "e4DV06jqnKT", "uri": "/contracts/e4DV06jqnKT#research-program-term", "label": "Collaborative Research and License Agreement (Archemix Corp.)", "score": 21.0, "published": true}], "snippet_links": [{"key": "the-research-program", "type": "clause", "offset": [0, 20]}, {"key": "on-the-effective-date", "type": "clause", "offset": [36, 57]}, {"key": "day-of", "type": "clause", "offset": [92, 98]}], "size": 4, "snippet": "The Research Program shall commence on the Effective Date and shall continue until the last day of the Research Program Term.", "hash": "ad926991780d04db8e23e96b7018a05a", "id": 7}, {"samples": [{"hash": "4nfSTuejOS", "uri": "/contracts/4nfSTuejOS#research-program-term", "label": "Collaborative Research and License Agreement (Accelrys, Inc.)", "score": 22.1991786448, "published": true}, {"hash": "6Cmci8nWpw5", "uri": "/contracts/6Cmci8nWpw5#research-program-term", "label": "Collaborative Research and License Agreement (Symyx Technologies Inc)", "score": 18.0, "published": true}, {"hash": "3a1B7sj7ZEN", "uri": "/contracts/3a1B7sj7ZEN#research-program-term", "label": "Collaborative Research and License Agreement (Symyx Technologies Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "the-research-program", "type": "clause", "offset": [0, 20]}, {"key": "on-the-effective-date", "type": "clause", "offset": [41, 62]}, {"key": "period-of", "type": "definition", "offset": [121, 130]}, {"key": "other-period", "type": "definition", "offset": [156, 168]}, {"key": "the-parties", "type": "definition", "offset": [172, 183]}, {"key": "mutually-agree", "type": "definition", "offset": [188, 202]}, {"key": "in-writing", "type": "clause", "offset": [203, 213]}], "size": 4, "snippet": "The Research Program Term shall commence on the Effective Date and, unless earlier terminated, continue thereafter for a period of three (3) years, or such other period as the parties may mutually agree in writing.", "hash": "00a7c340bfc217734347226dbeca35fa", "id": 8}, {"samples": [{"hash": "lUxARgBBIhc", "uri": "/contracts/lUxARgBBIhc#research-program-term", "label": "Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc)", "score": 21.0, "published": true}, {"hash": "ePX5lywshZJ", "uri": "/contracts/ePX5lywshZJ#research-program-term", "label": "Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc)", "score": 21.0, "published": true}, {"hash": "7VNr3vLpk6y", "uri": "/contracts/7VNr3vLpk6y#research-program-term", "label": "Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "except-as-otherwise-provided", "type": "clause", "offset": [0, 28]}, {"key": "the-research-program", "type": "clause", "offset": [37, 57]}, {"key": "on-the-effective-date", "type": "clause", "offset": [78, 99]}, {"key": "period-of", "type": "definition", "offset": [119, 128]}, {"key": "initial-research-program-term", "type": "definition", "offset": [148, 177]}, {"key": "sole-discretion", "type": "clause", "offset": [199, 214]}, {"key": "an-additional", "type": "clause", "offset": [253, 266]}, {"key": "year-period", "type": "definition", "offset": [275, 286]}, {"key": "notice-of", "type": "clause", "offset": [323, 332]}, {"key": "prior-to-the", "type": "clause", "offset": [372, 384]}, {"key": "first-anniversary", "type": "definition", "offset": [385, 402]}, {"key": "in-the-event-of", "type": "definition", "offset": [429, 444]}, {"key": "by-merck", "type": "clause", "offset": [459, 467]}, {"key": "the-parties-shall", "type": "clause", "offset": [468, 485]}, {"key": "in-good-faith", "type": "definition", "offset": [486, 499]}, {"key": "amendments-to-the-research-plan", "type": "clause", "offset": [525, 556]}, {"key": "without-limitation", "type": "clause", "offset": [584, 602]}, {"key": "number-of", "type": "clause", "offset": [608, 617]}, {"key": "extended-term", "type": "definition", "offset": [678, 691]}, {"key": "mutual-written-agreement", "type": "clause", "offset": [757, 781]}, {"key": "representative-of-the-parties", "type": "clause", "offset": [800, 829]}, {"key": "confidential-treatment-requested", "type": "definition", "offset": [870, 902]}, {"key": "the-foregoing", "type": "definition", "offset": [940, 953]}, {"key": "extended-research-program-term", "type": "definition", "offset": [1029, 1059]}], "size": 3, "snippet": "Except as otherwise provided herein, the Research Program Term shall commence on the Effective Date and continue for a period of one (1) year (the \"Initial Research Program Term\"). Merck may, in its sole discretion, extend the Research Program Term for an additional one (1) year period by providing Metabasis with written notice of such election at least sixty (60) days prior to the first anniversary of the Effective Date and in the event of such election by Merck the Parties shall in good faith agree upon any necessary amendments to the Research Plan, as applicable, including, without limitation, the number of Metabasis FTEs to be committed and funded by Merck for such extended term. Thereafter, the Parties may extend the Research Program Term by mutual written agreement of the authorized representative of the Parties, and shall, in such case, amend the *** Confidential Treatment Requested Research Plan as applicable. Each of the foregoing extensions of the Research Program Term shall be referred to herein as an \"Extended Research Program Term.\"", "hash": "72d773b5d92d449c81ddd9940d895967", "id": 9}, {"samples": [{"hash": "yxQEz1Xf7P", "uri": "/contracts/yxQEz1Xf7P#research-program-term", "label": "Collaborative Research and License Agreement (Targacept Inc)", "score": 21.0, "published": true}, {"hash": "dhwpoHoGgwj", "uri": "/contracts/dhwpoHoGgwj#research-program-term", "label": "Collaborative Research and License Agreement (Targacept Inc)", "score": 21.0, "published": true}, {"hash": "d1LHv8ZOHGU", "uri": "/contracts/d1LHv8ZOHGU#research-program-term", "label": "Collaborative Research and License Agreement (Targacept Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "the-research-program", "type": "clause", "offset": [0, 20]}, {"key": "on-the-effective-date", "type": "clause", "offset": [36, 57]}, {"key": "in-accordance-with", "type": "definition", "offset": [89, 107]}, {"key": "section-1122", "type": "clause", "offset": [108, 122]}, {"key": "fourth-anniversary", "type": "definition", "offset": [168, 186]}, {"key": "the-parties", "type": "definition", "offset": [232, 243]}, {"key": "in-writing", "type": "clause", "offset": [254, 264]}, {"key": "end-of-the-term", "type": "clause", "offset": [278, 293]}, {"key": "provided-that", "type": "clause", "offset": [325, 338]}, {"key": "for-purposes-of", "type": "clause", "offset": [340, 355]}, {"key": "pursuant-to-section", "type": "definition", "offset": [403, 422]}, {"key": "date-of", "type": "clause", "offset": [445, 452]}, {"key": "termination-shall", "type": "clause", "offset": [458, 475]}, {"key": "day-of", "type": "clause", "offset": [488, 494]}], "size": 3, "snippet": "The Research Program shall commence on the Effective Date and, unless terminated earlier in accordance with Section 11.2.2, shall continue until the earlier of (a) the fourth anniversary of the Effective Date, or such later date as the Parties may agree in writing, and (b) the end of the Term (the \u201cResearch Program Term\u201d); provided that, for purposes of clarity, if the Research Program is terminated pursuant to Section 11.2.2, the effective date of such termination shall be the last day of the Research Program Term.", "hash": "b51a63244bc07c8fc63fde324778a861", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih5yZXNlYXJjaC1wcm9ncmFtLXRlcm0jMDAwMDAwMGEMogECZW4YACAA", "clause": {"parents": [["research-program", "Research Program"], ["research-program-and-governance", "Research Program and Governance"], ["general", "General"], ["term-and-termination-of-research-program", "Term and Termination of Research Program"], ["research-program-term", "Research Program Term"]], "size": 141, "title": "Research Program Term", "children": [["term", "Term"], ["research-program-term-for-selected-multispecific-target-combinations", "Research Program Term for Selected Multispecific Target Combinations"], ["research-program-term-for-target-combinations", "Research Program Term for [\u2026***\u2026] Target Combinations"], ["research-program-term-for-the-target", "Research Program Term for the Target"], ["extensions", "Extensions"]], "id": "research-program-term", "related": [["research-program", "Research Program", "Research Program"], ["research-term", "Research Term", "Research Term"], ["research-collaboration", "Research Collaboration", "Research Collaboration"], ["research-plan", "Research Plan", "Research Plan"], ["research-project", "Research Project", "Research Project"]], "related_snippets": [], "updated": "2025-07-07T12:37:53+00:00"}, "json": true, "cursor": ""}}